Recognized as Place of research
15
Dec
Share
No Comments on Researchers create an antibody test to monitor SARS-CoV-2 variant immunity Antibody
Researchers create an antibody test to monitor SARS-CoV-2 variant immunity
Understanding the immune memory and tracking variant immunity to the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is vital for improving the continuous diagnosis and enhancing treatment in form of vaccines for any future outbreaks. Monitoring the variant immunity for SARS-CoV-2 spike[…]
Read More15
Dec
Share
No Comments on Bispecific antibodies’ evolution Antibody, Monoclonal Antibodies
Bispecific antibodies’ evolution
The very first monoclonal antibody approved by the U.S. FDA (Food and Drug Administration) in 1997 ushered a new era in therapeutic applications for patients. A clinical breakthrough was acknowledged in the 1990s when there was the successful development of a humanized[…]
Read More11
Jun
Share
No Comments on Therapeutic Monoclonal Antibodies And Its Increasing Importance In The Healthcare Antibody
Therapeutic Monoclonal Antibodies And Its Increasing Importance In The Healthcare
Treatment of diseases arose with the concept of antibodies back in the 1890s, by Emil Adolf von Behring. In the further 1960s, there were structural characteristics describers, forward marking discovery of production methods of Monoclonal Antibodies (mAbs). The first mAb, muromonab-CD3, was[…]
Read More10
Jun
Share
No Comments on Use Of Golimumab In The Treatment Of Rheumatoid Arthritis, Psoriatic Arthritis, Or Ankylosing Spondylitis Antibody
Use Of Golimumab In The Treatment Of Rheumatoid Arthritis, Psoriatic Arthritis, Or Ankylosing Spondylitis
Golimumab has been principally targeting and neutralizing TNF proving itself as a valuable human anti-tumor necrosis factor (TNF) monoclonal antibody, actively preventing inflammation and destruction of cartilage and bone. Golimumab, monoclonal antibody production, is largely represented by the biological community. 1. Sequential[…]
Read More
